v3.24.0.1
Equity - PRSU and RSU Activity (Details)
 12 Months Ended
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share [Abstract]      
Adjustment factor     1.7
Performance Shares [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Number of units, nonvested, beginning balance (in shares) | shares 260,797 366,075 430,236
Granted (in shares) | shares 121,352 192,921 146,322
Vested (in shares) | shares (164,948) (230,310) (113,991)
Forfeited and expired (in shares) | shares 0 (35,516) (96,492)
Adjustment due to ESAB Separation (in shares) | shares   (32,373)  
Number of units, nonvested, ending balance (in shares) | shares 217,201 260,797 366,075
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share [Abstract]      
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares $ 77.34 $ 72.13 $ 59.70
Granted (in usd per share) | $ / shares 71.80 47.89 77.84
Vested (in usd per share) | $ / shares 82.96 49.69 52.75
Forfeited and expired (in usd per share) | $ / shares 0 46.07 48.30
Adjustment due to ESAB Separation (in usd per share) | $ / shares   46.07  
Weighted-average grant date fair value, nonvested, ending balance (in usd per share) | $ / shares $ 69.97 $ 77.34 $ 72.13
Restricted Stock Units (RSUs) [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Number of units, nonvested, beginning balance (in shares) | shares 503,279 645,217 489,654
Granted (in shares) | shares 303,350 303,752 464,279
Vested (in shares) | shares (253,791) (243,485) (248,405)
Forfeited and expired (in shares) | shares (44,857) (70,914) (60,311)
Adjustment due to ESAB Separation (in shares) | shares   (131,291)  
Number of units, nonvested, ending balance (in shares) | shares 507,981 503,279 645,217
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share [Abstract]      
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares $ 71.33 $ 69.44 $ 55.06
Granted (in usd per share) | $ / shares 57.43 67.58 78.84
Vested (in usd per share) | $ / shares 71.55 64.11 51.71
Forfeited and expired (in usd per share) | $ / shares 63.43 69.22 63.95
Adjustment due to ESAB Separation (in usd per share) | $ / shares   71.52  
Weighted-average grant date fair value, nonvested, ending balance (in usd per share) | $ / shares $ 63.59 $ 71.33 $ 69.44